News

Dr. Reddy’s US generics business drags Q1 earnings, eyes weight-loss drug launch in 87 countries
The drugmaker plans to launch Semaglutide in 87 countries next year, including those where patents are expiring and emerging ...
The rebound effect: After stopping anti-obesity medications, patients regain weight rapidly
The study found that weight regain varied with follow-up, with participants experiencing weight regain at eight, 12, and 20 ...
Jim Cramer on Eli Lilly: “It Needs Breakthroughs in New Areas”
Eli Lilly and Company (NYSE:LLY) is one of the stocks that Jim Cramer shed light on. While Cramer still backed the company, he did express uncertainty about its future as he stated: “What I’m thinking ...